Alessandra Capital Management
PRME icon

Alessandra Capital Management’s Prime Medicine PRME Stock Holding History

Alessandra Capital Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.45M Buy
800,773
+134,170
+20% +$446K 1.72% 12
2026
Q2 		$2.46M Buy
666,603
+241,093
+57% +$801K 1.74% 12
2026
Q1 		$1.48M Buy
+425,510
New +$1.62M 1.26% 24

Other funds holding PRME

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Green Alpha Advisors
Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
Pekin Hardy Strauss
Pekin Hardy Strauss Chicago, Illinois $1.14B AUM 25.53% 1-Year Est. Return
MAM
Milestone Asset Management Pittsburgh, Pennsylvania $631M AUM 19.95% 1-Year Est. Return
Oppenheimer & Co
Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Alessandra Capital Management's PRME Position: Q3 2026 in Review

Alessandra Capital Management increased its Prime Medicine (PRME) stake by 20% in Q3 2026, buying an estimated $446K and bringing the position to 800,773 shares worth $2.45M. The position accounts for 1.72% of the portfolio, ranked #12.

Alessandra Capital Management first reported a position in PRME in Q1 2026 and has held it in 3 quarters since. The position peaked at $2.46M in Q2 2026. 47 funds tracked by Wall St. Rank hold PRME as of Q3 2026.

  • Alessandra Capital Management held 800,773 shares of Prime Medicine worth $2.45M as of Q3 2026.
  • Alessandra Capital Management bought 134,170 Prime Medicine shares in Q3 2026, an estimated $446K.
  • Prime Medicine made up 1.72% of Alessandra Capital Management's portfolio in Q3 2026, its #12 holding.
  • Alessandra Capital Management first reported a position in Prime Medicine in Q1 2026 and has held it in 3 quarters since.
  • Alessandra Capital Management's Prime Medicine position peaked at $2.46M in Q2 2026.
  • 47 funds tracked by Wall St. Rank held Prime Medicine as of Q3 2026.

Based on Alessandra Capital Management's 13F filing for Q3 2026, filed 30 Oct 2026.